Dr Edward Seehwan Kwon, MD | |
525 N Garfield Ave, Monterey Park, CA 91754-1202 | |
(626) 573-2222 | |
Not Available |
Full Name | Dr Edward Seehwan Kwon |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 25 Years |
Location | 525 N Garfield Ave, Monterey Park, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821041906 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | A94775 (California) | Primary |
207R00000X | Internal Medicine | A94775 (California) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Ahmc Anaheim Regional Medical Center | Anaheim, CA | Hospital |
West Anaheim Medical Center | Anaheim, CA | Hospital |
Garden Grove Hospital & Medical Center | Garden grove, CA | Hospital |
Garfield Medical Center | Monterey park, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Westside Anesthesia Services | 2860684248 | 32 |
Medvantage Anesthesia Care Inc | 8628350584 | 15 |
Anesthesia Specialists Of Orange County, Inc. | 9830289388 | 17 |
News Archive
Researchers in the United States have developed an inhibitor of the spike protein found on the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that limits its formation in host human cells that would otherwise be the source of newly generated virions.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
The retrospective cohort study evaluated the histories of more than 1.1 million adults who were patients of Kaiser Permanente between 1996 and 2000. The average age of the group studied was 52 years; 55% of the group was female.
Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.
› Verified 4 days ago
Entity Name | Anesthesia Specialists Of Orange County, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134311319 PECOS PAC ID: 9830289388 Enrollment ID: O20071220000220 |
News Archive
Researchers in the United States have developed an inhibitor of the spike protein found on the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that limits its formation in host human cells that would otherwise be the source of newly generated virions.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
The retrospective cohort study evaluated the histories of more than 1.1 million adults who were patients of Kaiser Permanente between 1996 and 2000. The average age of the group studied was 52 years; 55% of the group was female.
Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.
› Verified 4 days ago
Entity Name | Westside Anesthesia Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528381704 PECOS PAC ID: 2860684248 Enrollment ID: O20101004000677 |
News Archive
Researchers in the United States have developed an inhibitor of the spike protein found on the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that limits its formation in host human cells that would otherwise be the source of newly generated virions.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
The retrospective cohort study evaluated the histories of more than 1.1 million adults who were patients of Kaiser Permanente between 1996 and 2000. The average age of the group studied was 52 years; 55% of the group was female.
Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.
› Verified 4 days ago
Entity Name | Medvantage Anesthesia Care Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598110066 PECOS PAC ID: 8628350584 Enrollment ID: O20170130000748 |
News Archive
Researchers in the United States have developed an inhibitor of the spike protein found on the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that limits its formation in host human cells that would otherwise be the source of newly generated virions.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
The retrospective cohort study evaluated the histories of more than 1.1 million adults who were patients of Kaiser Permanente between 1996 and 2000. The average age of the group studied was 52 years; 55% of the group was female.
Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.
› Verified 4 days ago
Entity Name | Hypnos Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295449866 PECOS PAC ID: 9234583402 Enrollment ID: O20230922000468 |
News Archive
Researchers in the United States have developed an inhibitor of the spike protein found on the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that limits its formation in host human cells that would otherwise be the source of newly generated virions.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
The retrospective cohort study evaluated the histories of more than 1.1 million adults who were patients of Kaiser Permanente between 1996 and 2000. The average age of the group studied was 52 years; 55% of the group was female.
Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Edward Seehwan Kwon, MD 210 N Tustin Ave, Santa Ana, CA 92705-3807 Ph: (714) 347-1000 | Dr Edward Seehwan Kwon, MD 525 N Garfield Ave, Monterey Park, CA 91754-1202 Ph: (626) 573-2222 |
News Archive
Researchers in the United States have developed an inhibitor of the spike protein found on the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that limits its formation in host human cells that would otherwise be the source of newly generated virions.
IBBL will over the next three years contribute to the Interreg project Codex4SMEs. The € 3.13 million project aims to build a transnational network to accelerate the development of so-called companion diagnostics by small and medium-sized businesses and hence to promote personalized medicine in Europe.
The retrospective cohort study evaluated the histories of more than 1.1 million adults who were patients of Kaiser Permanente between 1996 and 2000. The average age of the group studied was 52 years; 55% of the group was female.
Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.
› Verified 4 days ago
Daniel Garcia, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-307-2120 | |
Dr. Igor Lovrincevic, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 716-861-7784 | |
Dae Yong Lee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 880 S Atlantic Blvd, Ste G 10, Monterey Park, CA 91754 Phone: 626-872-6261 Fax: 626-872-1948 | |
Dr. Claudia Villalpando Leon, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-573-2222 Fax: 626-307-2186 | |
Dr. Cynthia Chinn, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-573-2222 | |
Dr. Cynthia Rita Dabish, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 525 N Garfield Ave, Monterey Park, CA 91754 Phone: 626-573-2222 | |
Dr. Pei-jen Hwang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 235 W Gleason St, Monterey Park, CA 91754 Phone: 813-598-8693 |